US6764697B1
(en)
*
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
WO1994004135A1
(en)
*
|
1992-08-13 |
1994-03-03 |
Teikoku Seiyaku Kabushiki Kaisha |
Oral preparation for release in lower digestive tracts
|
US5356634A
(en)
*
|
1992-11-13 |
1994-10-18 |
Eastman Chemical Company |
Controlled-release delivery system
|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
US5843479A
(en)
*
|
1993-02-26 |
1998-12-01 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
JP2917799B2
(ja)
*
|
1994-03-11 |
1999-07-12 |
田辺製薬株式会社 |
消化管内適所放出型製剤
|
US5508276A
(en)
*
|
1994-07-18 |
1996-04-16 |
Eli Lilly And Company |
Duloxetine enteric pellets
|
US5849327A
(en)
*
|
1994-07-29 |
1998-12-15 |
Advanced Polymer Systems, Inc. |
Delivery of drugs to the lower gastrointestinal tract
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
US5637319A
(en)
*
|
1995-03-01 |
1997-06-10 |
Takada; Kanji |
Controlled-release preparations
|
US5686106A
(en)
*
|
1995-05-17 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form for colonic delivery
|
SG80553A1
(en)
*
|
1995-07-20 |
2001-05-22 |
Tanabe Seiyaku Co |
Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
|
AU1751997A
(en)
*
|
1996-01-30 |
1997-08-22 |
Advanced Polymer Systems Inc. |
Targeted delivery of drugs to the lower gastrointestinal tract
|
JPH10513202A
(ja)
*
|
1996-06-11 |
1998-12-15 |
ゾナジェン,インコーポレイテッド |
キトサン薬物送達システム
|
US5891474A
(en)
*
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
US5788987A
(en)
*
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US6248362B1
(en)
*
|
1997-03-26 |
2001-06-19 |
Meiji Seika Kaisha, Ltd. |
Large intestinal delivery composite
|
DE19732903A1
(de)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
KR100501022B1
(ko)
|
1998-07-28 |
2005-07-18 |
다나베 세이야꾸 가부시키가이샤 |
장내 적소 방출형 제제
|
WO2000074720A1
(fr)
*
|
1999-06-09 |
2000-12-14 |
Mochida Pharmaceutical Co., Ltd. |
Systeme de liberation dans les voies digestives inferieures
|
JP4524009B2
(ja)
*
|
1999-08-09 |
2010-08-11 |
大日本住友製薬株式会社 |
大腸内放出性カプセル製剤
|
EP1203590B1
(de)
*
|
1999-08-09 |
2007-07-04 |
Dainippon Sumitomo Pharma Co., Ltd. |
Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung
|
US6475493B1
(en)
|
1999-09-02 |
2002-11-05 |
Norstrum Pharmaceuticals, Inc. |
Controlled release pellet formulation
|
AUPQ672800A0
(en)
*
|
2000-04-06 |
2000-05-04 |
Natraherbal Pty Ltd |
Garlic supplement for deodoriser
|
TWI241195B
(en)
*
|
2000-04-10 |
2005-10-11 |
Shionogi & Co |
Preventive agent for bile acidic diarrhea
|
JP4875277B2
(ja)
*
|
2000-06-16 |
2012-02-15 |
田辺三菱製薬株式会社 |
放出pH域及び/又は速度制御組成物
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
KR100404769B1
(ko)
*
|
2001-01-31 |
2003-11-10 |
주식회사 비에스텍 |
팬에 부착된 향 송풍장치
|
AU2002244295B2
(en)
*
|
2001-03-13 |
2006-02-09 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms containing glucocorticosteroid
|
KR100413114B1
(ko)
*
|
2001-03-30 |
2003-12-31 |
재단법인서울대학교산학협력재단 |
키토산으로 표면 코팅된 조직 재생용 생분해성 고분자제제 및 그 제조방법
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
DE102004040243A1
(de)
*
|
2003-08-22 |
2005-03-17 |
Heppe, Katja, Dipl.-Biotechnol. |
Transportsystem auf Chitosanbasis
|
KR100782918B1
(ko)
*
|
2003-09-19 |
2007-12-07 |
펜웨스트 파머슈티칼즈 컴파니 |
지연 방출성 제형
|
EP1663156A2
(de)
*
|
2003-09-19 |
2006-06-07 |
Penwest Pharmaceuticals Company |
Chronotherapeutische dosierformen
|
CA2554771A1
(en)
|
2004-01-30 |
2005-08-18 |
Johns Hopkins University |
Nitroxyl progenitor compounds and methods of use
|
WO2005102292A1
(en)
*
|
2004-03-23 |
2005-11-03 |
Lytone Enterprise, Inc. |
Chitosan embedded or encapsulated capsule
|
CN1956707B
(zh)
*
|
2004-03-26 |
2010-12-29 |
力奇制药公司 |
包含n-(2-(2-苯二酰亚氨基乙氧基)-乙酰基)-l-丙氨酰基-d-谷氨酸(lk-423)的耐胃酸的药物剂型
|
US8007827B2
(en)
*
|
2004-04-02 |
2011-08-30 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties
|
US20050220873A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
|
US20050226927A1
(en)
*
|
2004-04-02 |
2005-10-13 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
|
CA2572223C
(en)
|
2004-06-25 |
2014-08-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
EP2324886A1
(de)
|
2005-07-29 |
2011-05-25 |
Concert Pharmaceuticals Inc. |
Neue deuterierte Analoga des Tadalafils
|
WO2007016338A2
(en)
*
|
2005-07-29 |
2007-02-08 |
Goverment Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Use of chk2 kinase inhibitors for cancer treatment
|
WO2007109175A1
(en)
|
2006-03-17 |
2007-09-27 |
Johns Hopkins University School Of Medicine |
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
|
JP5052051B2
(ja)
*
|
2006-06-16 |
2012-10-17 |
トーアエイヨー株式会社 |
腸溶性顆粒剤及びその製造方法
|
WO2008075448A1
(ja)
*
|
2006-12-21 |
2008-06-26 |
Aicello Chemical Co., Ltd. |
キトサン溶液及び該溶液から形成されたキトサンコーティング製剤
|
CA2675755C
(en)
|
2007-01-19 |
2015-10-06 |
Xcovery, Inc. |
Pyridine and pyridazine derivatives as kinase inhibitors
|
AU2008304200B2
(en)
*
|
2007-09-26 |
2013-12-19 |
Cardioxyl Pharmaceuticals, Inc. |
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
|
KR101115501B1
(ko)
*
|
2007-11-30 |
2012-02-27 |
주식회사 키토라이프 |
시플로플록사신이 담지된 저분자량 수용성 키토산 미립자에고분자가 코팅된 다중입자 및 이의 제조방법
|
PL2278975T3
(pl)
|
2008-05-07 |
2017-02-28 |
Cardioxyl Pharmaceuticals Inc. |
Nowe związki nitrozowe jako donory nitroksylu i metody ich zastosowania
|
JP5670325B2
(ja)
|
2008-06-19 |
2015-02-18 |
エックスカバリー ホールディング カンパニー エルエルシー |
キナーゼ阻害化合物としての置換されたピリダジンカルボキサミド化合物
|
EP2350012B1
(de)
|
2008-10-06 |
2017-06-28 |
The Johns Hopkins University |
Chinolinverbindungen als angiogenese-, humane methioninaminopeptidase- und sirt1-hemmer sowie verfahren zur behandlung von erkrankungen
|
US20110160200A1
(en)
*
|
2009-11-23 |
2011-06-30 |
Cardioxyl Pharmaceuticals, Inc. |
Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
|
CN102753519B
(zh)
|
2009-12-07 |
2015-08-05 |
约翰斯霍普金斯大学 |
二酰基化的羟基胺衍生物
|
ES2719101T3
(es)
*
|
2009-12-07 |
2019-07-08 |
Univ Johns Hopkins |
Derivados de hidroxilamina N-acilados y derivados de hidroxilamina o-acilados
|
ES2610226T3
(es)
|
2010-10-08 |
2017-04-26 |
Xcovery Holding Company Llc |
Compuestos de 6-amino-piridazin-3-il-carboxamida sustituidos como moduladores de proteínas cinasas
|
US10653631B2
(en)
|
2011-09-07 |
2020-05-19 |
Roland SAUR-BROSCH |
Optimal colon targeting technology
|
AU2012305915B2
(en)
|
2011-09-07 |
2017-09-07 |
Roland Saur-Brosch |
Formulation for the controlled release of one or several substances in the digestive tract of a mammal
|
MX363306B
(es)
|
2011-10-17 |
2019-03-20 |
Univ Johns Hopkins |
Derivados del acido de meldrum, acido barbiturico y pirazolona sustituidos con hidroxilamina como donadores de nitroxilo (hno).
|
WO2014070919A1
(en)
|
2012-11-01 |
2014-05-08 |
The Johns Hopkins University |
Controlled hno release through intramolecular cyclization-elimination
|
JP5836980B2
(ja)
*
|
2013-01-11 |
2015-12-24 |
信越化学工業株式会社 |
薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
|
TR201802211T4
(tr)
|
2013-01-18 |
2018-03-21 |
Cardioxyl Pharmaceuticals Inc |
Geliştirilmiş terapötik indekse sahip nitroksil vericiler.
|
KR102341899B1
(ko)
|
2013-04-07 |
2021-12-21 |
더 브로드 인스티튜트, 인코퍼레이티드 |
개인맞춤화 신생물 백신을 위한 조성물 및 방법
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
JP7060324B2
(ja)
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
WO2015109210A1
(en)
|
2014-01-17 |
2015-07-23 |
Cardioxyl Pharmaceuticals, Inc. |
N-hydroxymethanesulfonamide nitroxyl donors
|
WO2015183839A1
(en)
|
2014-05-27 |
2015-12-03 |
Cardioxyl Pharmaceuticals, Inc. |
Pyrazolone derivatives as nitroxyl donors
|
WO2015183838A1
(en)
|
2014-05-27 |
2015-12-03 |
The Johns Hopkins University |
N-hydroxylamino-barbituric acid derivatives as nitroxyl donors
|
US9464061B2
(en)
|
2014-05-27 |
2016-10-11 |
The Johns Hopkins University |
N-hydroxylamino-barbituric acid derivatives
|
JP6435179B2
(ja)
*
|
2014-12-08 |
2018-12-05 |
フロイント産業株式会社 |
大腸ドラッグデリバリーシステム錠剤
|
EP3234130B1
(de)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Verfahren zum profiling vom t-zell-rezeptor-repertoire
|
WO2016100975A1
(en)
|
2014-12-19 |
2016-06-23 |
Massachsetts Institute Ot Technology |
Molecular biomarkers for cancer immunotherapy
|
MX2017008373A
(es)
|
2014-12-23 |
2017-10-19 |
Cerecor Inc |
Compuestos, composiciones y metodos.
|
CR20200476A
(es)
|
2015-05-20 |
2020-12-02 |
Dana Farber Cancer Inst Inc |
ANTÍGENOS COMPARTIDOS (Divisional 2017-0584)
|
KR20180038440A
(ko)
|
2015-06-09 |
2018-04-16 |
렉산 파마슈티컬스, 인코포레이티드 |
플루오로사이클로펜테닐시토신 용도 및 제조 방법
|
JP2018526392A
(ja)
|
2015-09-04 |
2018-09-13 |
レクサン ファーマシューティカルズ インコーポレイテッド |
キノキサリニル−ピペラジンアミドの使用方法
|
US20190346442A1
(en)
|
2016-04-18 |
2019-11-14 |
The Broad Institute, Inc. |
Improved hla epitope prediction
|
JP7089141B2
(ja)
|
2016-10-03 |
2022-06-22 |
ハンチョウ ハイライトゥル ファーマシューティカル カンパニー リミテッド |
新規なjak1選択的阻害剤およびその使用
|
EP3574116A1
(de)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Zusammensetzungen und verfahren zum nachweis einer mutanten variante eines polynukleotids
|
CN112352052A
(zh)
|
2018-05-04 |
2021-02-09 |
托利斯有限公司 |
激活上皮细胞和髓样细胞的tlr3配体
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
WO2020215037A1
(en)
|
2019-04-18 |
2020-10-22 |
The Regents Of The University Of Michigan |
Combination with checkpoint inhibitors to treat cancer
|
US20220193033A1
(en)
*
|
2019-04-30 |
2022-06-23 |
Dsm Ip Assets B.V. |
New delivery system for specific water-soluble vitamins
|
US20220226254A1
(en)
*
|
2019-04-30 |
2022-07-21 |
Dsm Ip Assets B.V. |
New delivery system for fat soluble vitamins
|
JP2023528805A
(ja)
|
2020-05-26 |
2023-07-06 |
ディオニス セラピューティクス インコーポレイテッド |
核酸人工ミニプロテオームライブラリー
|
EP4161508A1
(de)
|
2020-06-05 |
2023-04-12 |
Henry Ford Health System |
Dakalasvir zur verwendung bei der behandlung von lungen- und prostatakrebs
|
EP4267554A1
(de)
|
2020-12-22 |
2023-11-01 |
Mekanistic Therapeutics LLC |
Substituierte aminobenzylheteroarylverbindungen als egfr- und/oder pi3k-hemmer
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
EP4385510A1
(de)
|
2021-08-10 |
2024-06-19 |
Betta Pharmaceuticals Co., Ltd |
Verwendung von ensartinib oder einem salz davon bei der behandlung von krankheiten mit exon-skipping-mutation von met 14
|
WO2023076733A1
(en)
|
2021-11-01 |
2023-05-04 |
Dana-Farber Cancer Institute, Inc. |
Biologically selected nucleic acid artificial mini-proteome libraries
|
CN115192537B
(zh)
*
|
2022-07-27 |
2024-03-26 |
康普药业股份有限公司 |
一种甲磺酸萘莫司他组合物及其制备方法
|
CN117426267A
(zh)
*
|
2023-12-21 |
2024-01-23 |
山东科赛基农生物工程有限公司 |
水稻生产全程健康管理方法及其应用
|